Abound Wealth Management Myriad Genetics Inc Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Myriad Genetics Inc stock. As of the latest transaction made, Abound Wealth Management holds 7 shares of MYGN stock, worth $121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 9
22.22%
Holding current value
$121
Previous $221,000
13.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MYGN
# of Institutions
243Shares Held
92.8MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$264 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$175 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$144 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$95.8 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$76.6 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.4B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...